Skip to main content
Clinical Trials/IRCT20150706023084N17
IRCT20150706023084N17
Completed
Phase 3

Study of the effects of Anaheal plus supplement on inflammation and scarring caused by acne

Salamat Parmoon Amin Pharmaceutical company0 sites50 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Salamat Parmoon Amin Pharmaceutical company
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Salamat Parmoon Amin Pharmaceutical company

Eligibility Criteria

Inclusion Criteria

  • Acne scarring
  • Age range over 18 years

Exclusion Criteria

  • Allergy to pineapple, curcuma, celery, carrot and fennel
  • Renal failure (GFR\<30\)
  • liver failure (Child pugh B,C)
  • Hemophillia
  • Using two antiplatelet drug
  • Using one anti platelet and one anti coagulant drug

Outcomes

Primary Outcomes

Not specified

Similar Trials